Biomarker Breast Pap Test

• Conditions: Tumors

• Registration Number: NCT01683305
• Lead Sponsor: Silbiotech

Brief Summary

This will be a Phase I study. During the Phase I study, our goals are: 1) screen a number of cancer biomarkers in Nipple Aspirate Fluid (NAF) from women who have no mammographically detectable tumors, and those who have detectable tumors, 2) identify all the detectable markers and 3) establish that biomarkers detected in NAF could also be detected in the biopsied tumor tissue that was removed for diagnostic purpose in subjects who have detectable tumors.

Detailed Description

Not available

Study Timeline

• Status Verified: 2012-09
• Study First Submitted: 2012-09-07
• Study First Submitted QC: 2012-09-10
• Last Update Submitted: 2012-09-10
• Study First Posted: 2012-09-11
• Last Update Posted: 2012-09-11
• Study Start: 2013-03
• Primary Completion: 2014-11
• Study Completion: 2014-11

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 500

Inclusion Criteria

• Any female subject aged 18 years or older

Exclusion Criteria

• none

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified